Skip to content

Enhanced Safety Aesthetic Laser System

Peterio™ - an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00495443
Enrollment
25
Registered
2007-07-03
Start date
2007-09-30
Completion date
2008-09-30
Last updated
2007-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirsutism, Hypertrichosis, Rhytides, Telangiectases

Brief summary

The purpose of this study is to determine whether a new laser system provides better safety and efficacy than existing lasers in popular cosmetic procedures such as hair removal, treatment of cosmetically disturbing vascular lesions and rhytides.

Detailed description

Cosmetic lasers are a well-established, popular modality for removal of unwanted hair, treatment of all types of vascular lesions, including hemangiomas, port wine stains, and a variety of telangiectases as well as facial rhytides reduction. The existing lasers are based on a wavelength that is specifically absorbed by the chromophore found in the target such as hair follicle, where the energy is converted to heat resulting in a thermal injury. However, the lasers for cosmetic treatments are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. Similar problem exists when targeting other chromophores such as hemoglobin or water. The purpose of the study is an evaluation of safety and efficacy of a new laser based device.

Interventions

DEVICEPeterio

Sponsors

Scilex Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 years old * Fitzpatrick skin types I to VI * Unwanted hair or/and * Aesthetically disturbing vascular lesions or/and * Facial rhytides

Exclusion criteria

* Age below 18 or above 75 year old. * Use of photosensitive medications * Photosensitive diseases * Active infection of any type and active infection or or a history of Herpes Simplex in the treated site * Exposure to sun or artificial tanning during the last 3-4 weeks * For treatment of facial rhytides- surgical or nonsurgical facial procedure (i.e., laser skin resurfacing, dermabrasion, phenol peel, nonablative laser, or temporary/permanent filler (e.g., collagen, fat, hyaluronic acid injections)

Design outcomes

Primary

MeasureTime frame
Hair, vascular lesions and wrinkles reduction as counted 1-3 months after each treatment session, depending on the treated area.

Secondary

MeasureTime frame
Measuring treatment discomfort as graded by the patients

Countries

Israel

Contacts

Primary ContactAlex Rapoport, BSC
alecr@netvision.net.il972-39506949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026